This finding is in line with our hypothesis, that cIP-10 (antagonist form) leads to an inefficient homing of CXCR3+ T cells at the site of infection (e.g. lung for tuberculosis or in the present study liver for HCV infection). The gene discussed is CXCR3; the disease is tuberculosis.